Cardiogenic Shock in other Heart Diseases: Acute Decompensation of Chronic Heart Failure, Myocarditis, Transient Apical Ballooning Syndrome, Peripartum Cardiomyopathy, Hypertrophic Cardiomyopathy, Restrictive Cardiomyopathies, and Thyrotoxicosis

2009 ◽  
pp. 172-199
Author(s):  
Fredric Ginsberg ◽  
Joseph E. Parrillo
2019 ◽  
Vol 2019 ◽  
pp. 1-7 ◽  
Author(s):  
Laurent Bonello ◽  
Marc Laine ◽  
Etienne Puymirat ◽  
Victoria Ceccaldi ◽  
Mélanie Gaubert ◽  
...  

Background. Cardiogenic shock (CS) remains a major challenge in contemporary cardiology. Data regarding CS etiologies and their prognosis are limited and mainly derived from tertiary referral centers. Aims. To investigate the current etiologies of cardiogenic shock and their associated short- and long-term outcomes in a secondary center without surgical back-up. Methods. We performed an observational prospective monocenter study. All patients admitted for a first episode of CS related to left ventricular dysfunction were enrolled. The definition of CS was consistent with the European Society of Cardiology guidelines. Patients were followed for 6 months. Etiologies were analyzed, and survival rates derived from Kaplan-Meier estimates were compared with the log-rank test. Results. Between January 2015 and January 2016, 152 patients were included. The first most common cause of CS was acute decompensation of chronic heart failure (CHF). Acute coronary syndromes (ACS) were the second most common cause of CS (35.4%). At one month, the all-cause mortality rate was 39.5% and was similar between ACS and CHF (43% vs 35%, respectively; p=0.7). In a landmark analysis between 1 and 6 months, we observed a significantly higher mortality in patients with CHF than in patients with ACS (18% vs. 0%; p=0.01). Conclusions. In the present registry, acute decompensation of chronic heart failure was the most common cause of CS, while ACS complicated by CS was the second most common cause. Of importance, acute decompensation of CHF was associated with a significantly worse outcome than ACS in the long term.


2020 ◽  
Vol 97 (1145) ◽  
pp. 175-179
Author(s):  
Nicolò Sisti ◽  
Serafina Valente ◽  
Giulia Elena Mandoli ◽  
Ciro Santoro ◽  
Carlotta Sciaccaluga ◽  
...  

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has spread in nearly 200 countries in less than 4 months since its first identification; accordingly, the coronavirus disease 2019 (COVID 2019) has affirmed itself as a clinical challenge. The prevalence of pre-existing cardiovascular diseases in patients with COVID19 is high and this dreadful combination dictates poor prognosis along with the higher risk of intensive care mortality. In the setting of chronic heart failure, SARS-CoV-2 can be responsible for myocardial injury and acute decompensation through various mechanisms. Given the clinical and epidemiological complexity of COVID-19, patiens with heart failure may require particular care since the viral infection has been identified, considering an adequate re-evaluation of medical therapy and a careful monitoring during ventilation.


2008 ◽  
Vol 149 (5) ◽  
pp. 365 ◽  
Author(s):  
Vincenzo De Santis ◽  
Domenico Vitale ◽  
Luigi Tritapepe ◽  
Cesare Greco ◽  
Paolo Pietropaoli

Sign in / Sign up

Export Citation Format

Share Document